MedPath

CoolSculpting the Upper Arm Study

Not Applicable
Completed
Conditions
Body Fat Disorder
Interventions
Device: CoolSculpting device with vacuum applicator.
Registration Number
NCT02669329
Lead Sponsor
Zeltiq Aesthetics
Brief Summary

Evaluate the safety and efficacy of the ZELTIQ CoolSculpting System using a specialized surface applicator for non-invasive subcutaneous fat reduction in the upper arm.

Detailed Description

This multi-center trial will evaluate the Zeltiq CoolSculpting treatment to perform treatments in the upper arm for the reduction subcutaneous fat reduction.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Upper arm treatment with vacuum applicatorCoolSculpting device with vacuum applicator.Subjects with clearly visible fat sufficient for treatment received bilateral CoolSculpting treatments, 1 treatment on each arm.
Primary Outcome Measures
NameTimeMethod
Percentage of Pre-treatment Images Correctly Identified12 weeks post treatment

Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images of the treated areas. The review panel will consist of practicing dermatologists or plastic surgeons. All reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form. Correct identification of photos by at least 2 of the 3 reviewers has an expected success rate of 75%.

Safety of the CoolSculpting Device in Upper Arm Treatments12 weeks post-treatment

The incidence of reported unanticipated adverse device effects (UADE) from the time of enrollment through the 12-week follow-up visit will be collected and analyzed. It is expected there will be zero UADE's reported.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Pacific Dermaesthetics

🇨🇦

Vancouver, British Columbia, Canada

Dr. Jean Carruthers Cosmetic Surgery Inc.

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath